← Leaderboards
Amit Singhal
Univ Of Massachusetts Med Sch Worcester
$3,635,183
Attributed
$8,237,976
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2019–24$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,237,976 · 4
By mechanism
R01$5,086,058 · 2
U01$2,902,833 · 1
R21$249,085 · 1
Top collaborators
- Hardy Kornfeld14 shared
- Robert S Wallis5 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Hardy Kornfeld$32,043,759
- Claudio Punzo$4,755,298
- Michael P Czech$34,170,723
- Pranoti Mandrekar$9,947,512
- John Anthony Haley$85,729
Others in their field
Other Emerging Leaders on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$49,374,001
- Prasant Mohapatra · University Of California At Davis$40,346,250
- Greg Yothers · University Of Chicago$35,003,821
Research focus
LungAntimicrobialPulmonary TuberculosisMediatingPathway InteractionsInfectionTuberculosis TreatmentMycobacterium TuberculosisTuberculosisResponseCellsTranscriptomicsAerosolsImmuneImpairmentSterilizationInflammationLung PreservationLung InjuryMacrophageImmunityHost DefenseSignal TransductionCd8b1 Gene
Grant awards (14)
Trial of Metformin for TB/HIV Host-directed Therapy$624,591
U01 · FY2024 · AI
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment$608,967
R01 · FY2024 · HL
Lung-Protective Mechanisms of Metformin in TB$604,331
R01 · FY2024 · HL
Unleashing CD8+ T Cells for TB Defense$249,085
R21 · FY2024 · AI
Lung-Protective Mechanisms of Metformin in TB$637,617
R01 · FY2023 · HL
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment$628,640
R01 · FY2023 · HL
Trial of Metformin for TB/HIV Host-directed Therapy$350,645
U01 · FY2023 · AI
Lung-Protective Mechanisms of Metformin in TB$647,877
R01 · FY2022 · HL
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment$636,398
R01 · FY2022 · HL
Trial of Metformin for TB/HIV Host-directed Therapy$567,738
U01 · FY2022 · AI
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment$663,956
R01 · FY2021 · HL
Lung-Protective Mechanisms of Metformin in TB$658,272
R01 · FY2021 · HL
Trial of Metformin for TB/HIV Host-directed Therapy$787,888
U01 · FY2020 · AI
Trial of Metformin for TB/HIV Host-directed Therapy$571,971
U01 · FY2019 · AI